 ‫ﺃ‬  ‫ﺟ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺖ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﻩ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺔ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﺘ‬  ‫ﺄ‬  ‫ﻛ‬  ‫ﺪ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﺍ‬  ‫ﺧ‬  ‫ﺘ‬  ‫ﻼ‬  ‫ﻑ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻐ‬  ‫ﻨ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﻡ‬  ‫ﻋ‬  ‫ﻨ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﻳ‬  ‫ﻌ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺑ‬  ‫ﻐ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  .   ‫ﻃ‬  ‫ﺮ‬  ‫ﻕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺒ‬  ‫ﺤ‬  ‫ﺚ‬  :  ‫ﺃ‬  ‫ﺟ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺖ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﻩ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻻ‬  ‫ﺳ‬  ‫ﺘ‬  ‫ﻌ‬  ‫ﺎ‬  ‫ﺩ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﻓ‬  ‫ﻲ‬  ‫ﻭ‬  ‫ﺣ‬  ‫ﺪ‬  ‫ﺓ‬  ‫ﻏ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺑ‬  ‫ﻤ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﺸ‬  ‫ﻔ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻠ‬  ‫ﻚ‬  ‫ﺧ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﻌ‬  ‫ﻲ‬  ٬  ‫ﺟ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﻌ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻠ‬  ‫ﻚ‬  ‫ﺳ‬  ‫ﻌ‬  ‫ﻮ‬  ‫ﺩ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺽ‬  ٬  ‫ﻋ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﻳ‬  ‫ﺨ‬  ‫ﻀ‬  ‫ﻌ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﻟ‬  ‫ﻐ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻧ‬  ‫ﺘ‬  ‫ﻈ‬  ‫ﺎ‬  ‫ﻡ‬  .  ‫ﺗ‬  ‫ﻢ‬  ‫ﺗ‬  ‫ﻮ‬  ‫ﺛ‬  ‫ﻴ‬  ‫ﻖ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺒ‬  ‫ﻴ‬  ‫ﺎ‬  ‫ﻧ‬  ‫ﺎ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻳ‬  ‫ﻤ‬  ‫ﻮ‬  ‫ﻏ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﻓ‬  ‫ﻴ‬  ‫ﺔ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ٬  ‫ﺑ‬  ‫ﻤ‬  ‫ﺎ‬  ‫ﻓ‬  ‫ﻴ‬  ‫ﻬ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﺆ‬  ‫ﺷ‬  ‫ﺮ‬  ‫ﻛ‬  ‫ﺘ‬  ‫ﻠ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﺴ‬  ‫ﻢ‬  ٬  ‫ﻭ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻯ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﻡ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻡ‬  ٬  ‫ﻭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻐ‬  ‫ﻨ‬  ‫ﻴ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﻡ‬  ٬  ‫ﻭ‬  ‫ﻫ‬  ‫ﺮ‬  ‫ﻣ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻐ‬  ‫ﺪ‬  ‫ﺓ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﺩ‬  ‫ﺭ‬  ‫ﻗ‬  ‫ﻴ‬  ‫ﺔ‬  ٬  ‫ﻭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻮ‬  ‫ﻟ‬  ‫ﻴ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﺮ‬  ‫ﻭ‬  ‫ﻝ‬  ٬  ‫ﻭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻫ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺜ‬  ‫ﻼ‬  ‫ﺛ‬  ‫ﻴ‬ ‫ﺎ‬  ‫ﻥ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻯ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻐ‬  ‫ﻨ‬  ‫ﻴ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬ ‫ﻡ‬ > ٠.٧ ‫ﻣ‬ ‫ﻤ‬ ‫ﻮ‬ ‫ﻝ‬ ⁄ ‫ﻝ‬ ٬ ‫ﻭ‬ ‫ﻛ‬ ‫ﺎ‬ ‫ﻥ‬ ‫ﻟ‬ ‫ﺪ‬ ‫ﻯ‬ ١٣ ) ١١.٣ ٪ ( ٧٬٠ ‫ﻣ‬ ‫ﻤ‬ ‫ﻮ‬ ‫ﻝ‬ ⁄ ‫ﻝ‬ ٬ ‫ﻭ‬ ‫ﻟ‬ ‫ﺪ‬ ‫ﻯ‬ ٢٤ ) ٢٠.٩ ٪ ( ٠.٨ ‫ﻣ‬ ‫ﻤ‬ ‫ﻮ‬ ‫ﻝ‬ ⁄ ‫ﻝ‬ ٬ ‫ﻭ‬ ‫ﻋ‬ ‫ﻨ‬ ‫ﺪ‬ ٢٦ ) ٢٢.٦ ٪ ( ‫ﻛ‬ ‫ﺎ‬ ‫ﻥ‬ ٠.٩ ‫ﻣ‬ ‫ﻤ‬ ‫ﻮ‬ ‫ﻝ‬ ⁄ ‫ﻝ‬ ٬ ‫ﻭ‬ ‫ﻋ‬ ‫ﻨ‬ ‫ﺪ‬ ١٦ ) ٩٬١٣ ٪ ( ٠٬١ ‫ﻣ‬ ‫ﻤ‬ ‫ﻮ‬ ‫ﻝ‬ ⁄ ‫ﻝ‬ ٬ ‫ﻭ‬ ٢٦ ) ٢٣.٩ ٪ ( ‫ﻇ‬ ‫ﻬ‬  ‫ﺮ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺕ‬  !  ١٬١  ‫ﻣ‬  ‫ﻤ‬  ‫ﻮ‬  ‫ﻝ‬  ⁄  ‫ﻝ‬  .  ‫ﺗ‬  ‫ﻘ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺒ‬  ‫ﺎ‬  ‫ﻛ‬  ‫ﺎ‬  ‫ﻥ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻯ‬  ٩٣  ٪  ‫ﻣ‬  ‫ﻦ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻌ‬  ‫ﻴ‬  ‫ﻨ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺗ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﻉ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺕ‬  ‫ﻫ‬  ‫ﺮ‬  ‫ﻣ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻐ‬  ‫ﺪ‬  ‫ﺓ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﺩ‬  ‫ﺭ‬  ‫ﻗ‬  ‫ﻴ‬ ‫ﺔ‬ ٬ ‫ﻭ‬ ٤٣ ) ٣٧.٤ ٪ ( ‫ﺍ‬ ‫ﻧ‬  ‫ﺨ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﺽ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻯ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﻡ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺪ‬ ‫ﻡ‬ ٬ ‫ﻭ‬ ٢٤ ) ٢٠.٩ ٪ ( ‫ﺍ‬ ‫ﻧ‬  ‫ﺨ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﺽ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻯ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻮ‬  ‫ﻟ‬  ‫ﻴ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﺮ‬  ‫ﻭ‬  ‫ﻝ‬  ‫ﻭ‬  ٦٠  )  ٢٬٥٢  ٪  (  ‫ﺍ‬  ‫ﻧ‬  ‫ﺨ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﺽ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻫ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺜ‬  ‫ﻼ‬  ‫ﺛ‬  ‫ﻴ‬  ‫ﺔ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻡ‬  .  ‫ﺃ‬  ‫ﻇ‬  ‫ﻬ‬  ‫ﺮ‬  ‫ﻣ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﻏ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺒ‬  ‫ﻴ‬  ‫ﺮ‬  ‫ﺗ‬  ‫ﻮ‬  ‫ﻧ‬  ‫ﻲ‬  ‫ﺍ‬  ‫ﻧ‬  ‫ﺨ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﺿ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﻠ‬  ‫ﺤ‬  ‫ﻮ‬  ‫ﻇ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻐ‬  ‫ﻨ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﻡ‬  ‫ﻭ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺗ‬  ‫ﻔ‬  ‫ﺎ‬  ‫ﻋ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺕ‬  ‫ﻫ‬  ‫ﺮ‬  ‫ﻣ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻐ‬  ‫ﺪ‬  ‫ﺓ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﺩ‬  ‫ﺭ‬  ‫ﻗ‬  ‫ﻴ‬  ‫ﺔ‬  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻘ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﻧ‬  ‫ﺔ‬  ‫ﺑ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﻏ‬  ‫ﺴ‬  ‫ﻴ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻣ‬  ‫ﻮ‬  ‫ﻱ‬  .   ‫ﺍ‬  ‫ﻻ‬  ‫ﺳ‬  ‫ﺘ‬  ‫ﻨ‬  ‫ﺘ‬  ‫ﺎ‬  ‫ﺟ‬  ‫ﺎ‬  ‫ﺕ‬  :  ‫ﻳ‬  ‫ﻌ‬  ‫ﺘ‬  ‫ﺒ‬  ‫ﺮ‬  ‫ﻣ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺰ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﻋ‬  ‫ﻤ‬  ‫ﻮ‬  ‫ﻣ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﻌ‬ 
Abstract
Objectives: Serum magnesium (Mg) levels are often altered in dialysis patients. This study was conducted to ascertain the trends in Mg levels in patients on dialysis treatment.
Methods: A retrospective study was performed in the Dialysis Unit of King Khalid University Hospital, King Saud University, Riyadh, on patients undergoing regular dialysis. Patient demographic data, including body mass index (BMI), serum calcium (Ca), Mg, parathyroid hormone (PTH), cholesterol, and triglycerides were documented.
Results: Of a total of 115 patients, 70 (60.9%) were on haemodialysis (HD), and 45 (39.1%) were on peritoneal dialysis (PD). Of these, 10 patients (8.7%) had Mg levels of <0.7 mmol/L, 13 (11.3%) had 0.7 mmol/L, 24 (20.9%) had 0.8 mmol/L, 26 (22.6%) had 0.9 mmol/L, 16 (13.9%) 1.0 mmol/L, and 26 (23.9%) showed levels of !1.1 mmol/ L. Approximately 93.0% had increased PTH levels, 43 (37.4%) had decreased serum Ca, 24 (20.9%) had low serum cholesterol, and 60 (52.2%) had low serum triglyceride. PD patients had significantly lower Mg and higher PTH levels compared to HD patients.
Conclusion:
Patients with chronic kidney disease are generally considered at risk of developing hypermagnesaemia due to reduced renal excretion. However, a considerable number of dialysis patients in our unit had Conversely, hypomagnesaemia is also seen not infrequently in ESRD patients on dialysis. This can be attributed to dietary restrictions, use of loop and thiazide diuretics, and lower concentration of Mg in the dialysate, leading to loss of Mg from the body. 5 Hypomagnesaemia is correlated to dyslipidaemia, thus predisposing the individual to vascular calcification, atherosclerosis, and cardiovascular mortality. 6 Low Mg þþ levels have been associated with impairment of myocardial contractility, intra-dialytic haemodynamic instability, hypertension, and thickening of the carotid inner wall linings. 7 In addition, dietary limitations for ESRD patients limit the intake of Mg rich foods, thus increasing the potential for hypomagnesaemia. A number of our dialysis patients have hypomagnesaemia, or low normal Mg levels, rather than the expected hypermagnesaemia. To investigate this issue further, we designed this study to understand the prevalence of hypermagnesaemia and hypomagnesaemia in relation to serum parathyroid and calcium levels, diet, and lipid profile of our dialysis patients.
Materials and Methods
This is a retrospective study (It is a cross-sectional study) performed in the Dialysis Unit of King Khalid University Hospital, King Saud University, Riyadh, KSA, covering patients seen between January 2011 and December 2011. All patients above 16 years of age, who were on regular haemodialysis (HD) (the magnesium content in the dialysate fluid in haemodialysis is 0.5 Mmol/L) or on peritoneal dialysis (PD) (the magnesium content in the peritoneal solution is 0.25 Mmol/L, as magnesium chloride) for more than three months, were included in the study. Patients with active infection or bone malignancy were excluded from the study. All HD patients used dialysate with Mg concentration of 0.5 mmol/L, while all PD patients used dialysate fluid with Mg concentration of 0.25 mmol/L. The blood samples were taken pre-dialysis.
Data analysis
For statistical analysis, descriptive data are expressed as the mean AE SD. Comparison between groups was performed using independent t-tests and chi-square tests. One-way ANOVA was performed to determine the relationship between groups of patients to PTH, calcium, cholesterol, and triglyceride levels. Post-hoc analysis was performed to determine the significance of normal, increased, and decreased Mg þþ levels with PTH, calcium, cholesterol, and triglyceride levels. Statistical analysis was performed separately on the study group as a whole, females only, males only, or according to BMI or type of dialysis (PD or HD). All statistical analyses were performed using Predictive Analysis Software version 18.0 (PASW, SPSS, IBM, Chicago, Illinois, USA). Statistical significance was fixed at a p value < 0.05.
Results
One hundred and fifteen patients (54 males and 61 females) were studied. Of these, there were 70 (60.9%) on HD and 45 (39.1%) on PD. Table 3 , along with results of Students' T Test.
We found that PD patients had lower levels of serum Mg compared to HD patients (Table 3 ). Among the 45 PD patients, 10 patients (22.22%) had Mg levels below the recommended normal levels, while none of the patients on HD had low magnesium levels. However, 23% of HD patients and 44.45% of PD patients had serum Mg levels in the low to normal range (<0.9 mmol/L). The distribution of Mg levels in both dialysis modalities is shown in Table 4 , Figure 1 . Conversely, recent studies suggest that hypomagnesaemia occurs more frequently among dialysis patients than previously realized. 18 This can be attributed to dietary restrictions for ESRD patients who limit the intake of Mgrich foods and concomitant use of loop and thiazide diuretics. Nonetheless, following the initiation of dialysis treatment, the major determinant of Mg þþ balance is the concentration gradient of Mg þþ between serum Mg levels and the dialysate, leading to an increased loss of Mg þþ during dialysis. Hypomagnesaemia in dialysis patients can lead to a number of symptoms, including anorexia, fatigue, and muscle weakness. As the deficiency worsens, muscle cramps, Nevertheless, analysing our data on the basis of dialysis modality indicates that patients on PD had overall lower Mg levels compared to HD patients. A significant number of patients on PD (>20%) had hypomagnesaemia (levels <0.7 mmol/L), while the majority of the remaining patients had Mg levels in the lower normal range (<0.9 mmol/L). On the other hand, none of the HD patients had hypomagnesaemia and 11% of HD patients had Mg levels above the normal range, compared to only 2% of PD patients. However, almost 23% of the HD patients had serum Mg levels in the low to normal range (<0.9 mmol/L). This can be attributed to the difference in dialysate Mg concentrations as well as dietary restrictions between PD and HD patients. Still, the laboratory results do not reveal the exact state of Mg in the body, and serum Mg levels can be normal even as cellular Mg is depleted. 22 Therefore, Mg deficiency in the dialysis population might be more widespread than is commonly realized. The higher prevalence of hypomagnesaemia seen in PD patients can be ascribed to the lower concentration of Mg in PD fluids compared to the HD dialysate used in our unit, and also to the relatively greater use of diuretics in PD patients, since more PD patients have residual renal function, especially at the start of dialysis. 23 
Conclusion
In view of the findings of the current study, we can conclude that hypomagnesaemia and Mg deficiency might be more prevalent among ESRD patients using renal replacement therapy (HD and PD) than is commonly realized. We found a significant correlation between serum Mg AEAE and PTH levels as well as to serum calcium levels. It is important to take into account the fact that serum Mg AEAE may be normal even though a state of intracellular depletion exists. 24 Consequently, optimizing the Mg AEAE concentration in dialysate to maintain serum levels in an acceptable range is essential to improving patient wellbeing and avoiding the complications of hypomagnesaemia, which include cardiac arrhythmias, hyperparathyroidism, and adynamic bone disease.
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